The PHADEBACT brand, founded in 1974 (Germany), from 1125 sister brands and 17477 competing brands. PHADEBACT is a brand of Pfizer Inc, listed on the stock exchange of New York. PHADEBACT is part of the Drug Manufacturers activity sector.
Investment simulator :
Portfolio valuation
Pfizer Inc
(PHADEBACT)
over 5 years*
USD 16.68